Eli Lilly Corp. buy Wolfe Research
Start price
03.12.25
/
50%
€890.10
Target price
03.12.26
€1,074.1
Performance (%)
20.57%
Price
28.07.26
€1,073.2
Summary
This prediction is currently active. The prediction currently has a performance of 20.57%. This prediction currently runs until 03.12.26. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | 4.154% | 4.154% |
| iShares Core DAX® | 1.717% | 3.368% |
| iShares Nasdaq 100 | -4.565% | -4.238% |
| iShares Nikkei 225® | -7.120% | -11.869% |
| iShares S&P 500 | -0.894% | 1.687% |
Comments by Wolfe_Research for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) had its price target raised by analysts at Wolfe Research from $1,050.00 to $1,250.00. They now have an "outperform" rating on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by Wolfe_Research for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€732.30
15.11.24
15.11.24
€946.80
15.11.25
15.11.25
20.70%
16.11.25
16.11.25

